Very recently, Hata et al. reported a pilot study taking into account GNAS alterations in ctDNA obtained from 57 patients with histologically diagnosed pancreatic cystic neoplasms (PCNs), 34 of which presenting IPMN [48]. This evidence concerns the gene GNAS and pancreatic intraductal papillary-mucinous neoplasm.